GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » Cash Flow from Financing

TMC Life Sciences Bhd (XKLS:0101) Cash Flow from Financing : RM-29.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2024, TMC Life Sciences Bhd paid RM0.0 Mil more to buy back shares than it received from issuing new shares. It spent RM3.8 Mil paying down its debt. It paid RM0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received RM0.0 Mil from paying cash dividends to shareholders. It received RM0.0 Mil on other financial activities. In all, TMC Life Sciences Bhd spent RM3.8 Mil on financial activities for the three months ended in Sep. 2024.


TMC Life Sciences Bhd Cash Flow from Financing Historical Data

The historical data trend for TMC Life Sciences Bhd's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd Cash Flow from Financing Chart

TMC Life Sciences Bhd Annual Data
Trend May14 May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 82.31 32.27 2.04 -29.66

TMC Life Sciences Bhd Quarterly Data
Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.49 -16.15 -4.50 -4.51 -4.57

TMC Life Sciences Bhd Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

TMC Life Sciences Bhd's Cash from Financing for the fiscal year that ended in Jun. 2024 is calculated as:

TMC Life Sciences Bhd's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-29.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TMC Life Sciences Bhd  (XKLS:0101) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

TMC Life Sciences Bhd's issuance of stock for the three months ended in Sep. 2024 was RM0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

TMC Life Sciences Bhd's repurchase of stock for the three months ended in Sep. 2024 was RM0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

TMC Life Sciences Bhd's net issuance of debt for the three months ended in Sep. 2024 was RM-3.8 Mil. TMC Life Sciences Bhd spent RM3.8 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

TMC Life Sciences Bhd's net issuance of preferred for the three months ended in Sep. 2024 was RM0.0 Mil. TMC Life Sciences Bhd paid RM0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

TMC Life Sciences Bhd's cash flow for dividends for the three months ended in Sep. 2024 was RM0.0 Mil. TMC Life Sciences Bhd received RM0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

TMC Life Sciences Bhd's other financing for the three months ended in Sep. 2024 was RM0.0 Mil. TMC Life Sciences Bhd received RM0.0 Mil on other financial activities.


TMC Life Sciences Bhd Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


TMC Life Sciences Bhd Business Description

Traded in Other Exchanges
N/A
Address
No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd Headlines

No Headlines